Pharmaphorum is an online publication on a mission to educate, inform, engage, and connect pharmaceutical industry leaders and to equip them to thrive in healthcare’s evolving digital future. Pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in

  • 86articles · 30d
  • 2+ day agolatest article
  • Aug 17, 2026earliest in window
  • 70%with images
  • 333avg words
articles per day
Categories
  • HTH 71
  • HW 63
  • health 45
  • BI 21
  • economy business and finance 19
  • science and technology 19
  • FIB 9
  • SCT 5

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

pharmaphorum
pharmaphorum.com > news > abbvie-charts-new-course-cgrps-menstrual-migraine

AbbVie charts a new course for CGRPs in menstrual migraine

2+ day, 8+ hour ago   (489+ words) AbbVie's Qulipta has become the first oral CGRP inhibitor to show efficacy in a phase 3 study involving women with menstrual migraine, which is severe and tends to resist current treatments. Qulipta (atogepant) has already become a blockbuster treatment after being…...

Web

External web results are waiting for the human check. Complete the press-and-hold control above. Google advertising and AI choices remain separate after verification.